CapitalBio Technology Co., Ltd., set up in 2012, is a leading life science company and the industrialization platform of CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. Headquartered in Beijing, China, it develops and commercializes healthcare offerings, such as biochip-based automation platforms and life science instruments. Its core products include microarray scanners, microfluidic chip analyzers, biochip hybridization stations, DNA sequencers, and genetic testing kits for applications in genomics, proteomics, and clinical diagnostics. Serving industries like healthcare, agriculture, and food safety, CapitalBio supports clients such as biomedical researchers and clinicians with offerings for infectious disease detection, fetal chromosomal aneuploidy screening, and HPV genotyping. The company operates globally, with certifications like ISO9001 and CNASL2451, and has strategic partnerships with firms like Affymetrix and Roche NimbleGen. CapitalBio’s innovations, such as its electromagnetic biochip, have earned awards like the National Technology Invention Award’s Second Prize.